Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Februar 2019

Planlagt Fastgjort Låst Flyttet Genmab
3.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #1078

    Just a moment...

    favicon

    (www.firstwordpharma.com)

    1 Reply Last reply
    0
    • SolsenS Offline
      SolsenS Offline
      Solsen
      wrote on sidst redigeret af
      #1079

      Hold da op. Så forstår jeg da ingenting af den handel BMY har gang i. Godt for Daras salg mener jeg tillige.

      1 Reply Last reply
      0
      • BulderB Offline
        BulderB Offline
        Bulder
        wrote on sidst redigeret af
        #1080

        Jeg troede ikke at det var allerede nu

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #1081

          Enig Solsen.

          1 Reply Last reply
          0
          • SolsenS Offline
            SolsenS Offline
            Solsen
            wrote on sidst redigeret af
            #1082

            Jeg har gravet meget i det. Men kom frem til 2022 på grundlag af mange artikler.

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #1083

              Så får de nok en patentsag på halsen 😉

              1 Reply Last reply
              0
              • H Offline
                H Offline
                Hamming
                wrote on sidst redigeret af
                #1084

                Just a moment...

                favicon

                (journals.lww.com)

                1 Reply Last reply
                0
                • H Offline
                  H Offline
                  Hamming
                  wrote on sidst redigeret af
                  #1085

                  Godt overblik

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #1086

                    Suverænt link. Tak Hamming.

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      peter12
                      wrote on sidst redigeret af
                      #1087

                      Mere om Revlimid http://www.gabionline.net/Generics/News/Alvogen-receives-European-approval-for-generic-lenalidomide

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #1088

                        Flere af disse patenter ser ud til at udløbe i 2020 https://www.drugs.com/availability/generic-revlimid.html

                        1 Reply Last reply
                        0
                        • BulderB Offline
                          BulderB Offline
                          Bulder
                          wrote on sidst redigeret af
                          #1089

                          Mystisk: The patents on Revlimid’s ‘last-to-expire’ key patents, according to C
                          elgene, are only due to expire in the US in 2027 and in Europe in 2024.

                          1 Reply Last reply
                          0
                          • SolsenS Offline
                            SolsenS Offline
                            Solsen
                            wrote on sidst redigeret af
                            #1090

                            Der kan være meget forskel på lande og verdensdele. Men det bliver et hullet tæppe som tiden går. Så vi ikke forleden "Doctor Reddys" der opgav - sikkert imod betaling fra CELG (Husker ikke navnet)

                            1 Reply Last reply
                            0
                            • SolsenS Offline
                              SolsenS Offline
                              Solsen
                              wrote on sidst redigeret af
                              #1091

                              CELG har gjort alt for at forlænge patentet og tillige købt konkurrenter til at opgive eller udsætte launch.

                              1 Reply Last reply
                              0
                              • BulderB Offline
                                BulderB Offline
                                Bulder
                                wrote on sidst redigeret af
                                #1092

                                Så nu bliver de nødt til at købe Genmab? 😉

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #1093

                                  Mike Thompson in good Dara mood today https://twitter.com/mtmdphd/status/1095658187859132416 https://twitter.com/mtmdphd/status/1095658194779676672

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    peter12
                                    wrote on sidst redigeret af
                                    #1094

                                    Endnu mere om Revlimid http://www.taipeitimes.com/News/biz/archives/2017/09/09/2003678067

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      peter12
                                      wrote on sidst redigeret af
                                      #1095

                                      Upon the expiration or loss of patent protection for a product, or upon the “at-risk” launch by a manufacturer of a generic version of one of our products, we can quickly lose a significant portion of our sales of that product. In addition, as additional competitors enter the market, our patented products may face increased competition or pricing pressure http://q4live.s22.clientfiles.s3-website-us-east-1.amazonaws.com/728481125/files/doc_financials/2018/b0b91209-0f73-447c-93ab-9027fb4c6bbf.pdf

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        peter12
                                        wrote on sidst redigeret af
                                        #1096

                                        Celgene skriver en del om det i det
                                        dokument, hvis man søger på "Our products may face competition"

                                        1 Reply Last reply
                                        0
                                        • B Offline
                                          B Offline
                                          bibob
                                          wrote on sidst redigeret af
                                          #1097

                                          Ja,- Så der lidt at smide af i morgen hvis det går som det plejer. Men måske venter de til efter regnskab og guiding. 😉

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger